People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Other Technology, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vascular Pharmaceuticals, Inc. | — | Biotechnology | Series B | $47.3M | $119.1M | 2012 |
| Yieldbot Inc. | — | Other Technology | Series A | $30.3M | $270.9M | 2012 |
| Basking Biosciences, Inc. | — | Biotechnology | Series B | $29.4M | $261.3M | 2020 |
| Sterifre Medical, Inc. | — | Healthtech | Series A | $15.9M | $23.6M | 2016 |
| Spiration Inc | — | Other Health Care | Series A | $13.5M | $131.2M | 2009 |
Richard Shea at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Shea on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eric Wiesen | 1 | 17 |
| Steve Gillis | 1 | 13 |
| Scott Johnson | 1 | 10 |
| Jeani Delagardelle | 1 | 8 |
| David Adair | 1 | 7 |
| Alan Kelley | 1 | 7 |
| Gerard Neumann | 1 | 6 |
| SCOTT C. JOHNSON | 1 | 6 |
| Richard Kent | 1 | 5 |
| Ryan Helon | 1 | 5 |
| Rebecca Robertson | 1 | 4 |
| Thomas Needham | 1 | 4 |
| Ken Williams | 1 | 3 |
| Dan Myers | 1 | 3 |
| Jonathan Mendez | 1 | 3 |
| Vaughn Kailian | 1 | 3 |
| Benjamin Rovinski | 1 | 3 |
| Paul Glass | 1 | 3 |
| Kevin Cahill | 1 | 3 |
| Cathleen Black | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.